Engene Holdings: Why 2026 Could Be Their Pivotal Moment

Vertex Pharmaceuticals Shines Bright: A Major Leap in Kidney Disease Treatment

A Glimmer of Hope for Kidney Disease: Vertex's Breakthrough in IgA Nephropathy

PROSTACT's Phase 3 Study Part 1: A Glimmer of Hope in Prostate Cancer Treatment

The FDA's Quiet Retreat: Fewer Public Debates Amid Rising Controversy

A Stinging Setback: Incyte's Cancer Therapy Fails to Clear FDA's High Bar

A Critical Eye on Progress: FDA Official Questions uniQure's Huntington's Trial Comparisons

The Uncharted Alliance: Klotho Neurosciences Forges Unexpected Path with Greenland Mining Giant

A Nuanced Look at Helus Pharma's HLP004 for Anxiety: Beyond the Primary Endpoint

The Shifting Sands of Pharma: FDA's Grip, Global Ambitions, and the Future of Medicine

A Major Setback: FDA Halts uniQure's Huntington's Gene Therapy Trial

Another Heartbreaking Setback in the Pursuit of Prader-Willi Syndrome Treatments

The End of an Era: Doug Ingram Prepares to Retire from Sarepta, Elizabeth Barrett Named Successor

Celldex Therapeutics Soars: Is a Game-Changing Skin Treatment on the Horizon?

GSK's Bold Gambit: $1.4 Billion Bet on Aiolos Bio for Pulmonary Hypertension Breakthrough

GSK's Bold Move: A $1.8 Billion Bet on the Future of Pulmonary Hypertension Treatment

Pfizer's Bold Gambit: A Nearly Half-Billion Dollar Bet on China's Obesity Market

A Glimmer of Hope for Crohn's Patients: Stoked Bio's Latest Leap Forward

Biogen Delivers a Welcome Surprise: Robust Profit Forecast Exceeds Expectations

Eli Lilly's Ascendant Journey: Why Its Premium Price Tag Might Just Be Worth It

Amgen's Bold Vision: CEO Taps 2026 as 'Springboard Year' for Monumental Growth

Pharmalot's Pulse Check: Navigating Pharma's Twists and Turns

AstraZeneca's Bold Bet: Charging Hard into China's Obesity Drug Race and Beyond

Absci's AI-Powered Drug Hunt: Unpacking the Potential of ABS-101 and ABS-201

Legend Biotech's Carvykti: A Beacon of Hope Reshaping Multiple Myeloma Treatment

A Beacon of Hope: BPGbio's BPM31510 Earns FDA Orphan Drug Status for Primary CoQ10 Deficiency

Corvus Pharmaceuticals Takes Key Step Forward with Lead Eczema Drug

The Unseen Engine of Medicine: Small Molecule API Market Poised for Explosive Growth

Amgen's Horizon: Bradway Shares Strategic Vision with Cramer

More Than Business: Incyte's Identity Forged in the Blood Cancer Battle

Unlocking New Frontiers: How Revolution Medicines and Merck Are Redefining the Cancer Fight

ArriVent BioPharma: Decoding the 'Cautious Buy' on Furmonertinib

Zevra Therapeutics: A High-Stakes Bet in the Ultra-Rare Disease Arena

The Silent Storm: Why Antimicrobial Resistance Threatens Everything We Know About Medicine

Prime: Unlocking a Brighter Future for Wilson's Disease and Beyond

Unpacking the Data: InflaRx's Continued Deep Dive into Vilobelimab for Pyoderma Gangrenosum

InflaRx's Vilobelimab: A Deeper Look into Pyoderma Gangrenosum Trial Data

The Dawn of AI-Driven Cures: Insilico Medicine's Historic Hong Kong Debut

A New Horizon for Essential Tremor: Praxis's Ulixacaltamide Earns Breakthrough Status